Birchview Capital, LP 13F holdings
Birchview Capital, LP reported 72 positions with a total reported value of $213.8M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: KLAC KLA CORPORATION (25.2%), BMY BRISTOL-MYERS SQUIBB CO (8.0%), LRCX LAM RESEARCH CORPORATION (7.1%), NTLA INTELLIA THERAPEUTICS INC (3.2%), SLDB SOLID BIOSCIENCES INC (3.1%). Against 2026-03-31 it opened 14 new positions and exited 15. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Birchview Capital, LP files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
25 largest of 72 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| KLAC KLA CORPORATION | 178,471 | $53.8M | 25.2% |
| BMY BRISTOL-MYERS SQUIBB CO | 297,243 | $17.1M | 8.0% |
| LRCX LAM RESEARCH CORPORATION | 35,000 | $15.2M | 7.1% |
| NTLA INTELLIA THERAPEUTICS INC | 385,900 | $6.8M | 3.2% |
| SLDB SOLID BIOSCIENCES INC | 666,196 | $6.7M | 3.1% |
| BDSX BIODESIX INC | 286,804 | $6.5M | 3.0% |
| STOK STOKE THERAPEUTICS INC | 178,110 | $5.8M | 2.7% |
| OVV OVINTIV INC | 107,500 | $5.7M | 2.6% |
| NKTR NEKTAR THERAPEUTICS | 81,000 | $5.7M | 2.6% |
| CORT CORCEPT THERAPEUTICS INC | 57,200 | $5.0M | 2.3% |
| NBIX NEUROCRINE BIOSCIENCES INC | 27,190 | $4.6M | 2.1% |
| PROTHENA CORP PLC | 449,019 | $4.4M | 2.1% |
| ACAD ACADIA PHARMACEUTICALS INC | 171,000 | $4.3M | 2.0% |
| PTGX PROTAGONIST THERAPEUTICS INC | 35,018 | $4.3M | 2.0% |
| CMPX COMPASS THERAPEUTICS INC | 1,675,000 | $3.7M | 1.7% |
| RLMD RELMADA THERAPEUTICS INC | 408,100 | $2.8M | 1.3% |
| ALKS ALKERMES PLC | 50,000 | $2.6M | 1.2% |
| HALO HALOZYME THERAPEUTICS INC | 33,251 | $2.6M | 1.2% |
| CLDX CELLDEX THERAPEUTICS INC | 69,900 | $2.6M | 1.2% |
| CYTK CYTOKINETICS INC | 30,000 | $2.6M | 1.2% |
| OLMA OLEMA PHARMACEUTICALS INC | 199,000 | $2.5M | 1.2% |
| VERA VERA THERAPEUTICS INC | 57,758 | $2.5M | 1.2% |
| UTHR UNITED THERAPEUTICS CORP | 4,506 | $2.4M | 1.1% |
| ZBIO ZENAS BIOPHARMA INC | 93,601 | $2.4M | 1.1% |
| QURE UNIQURE NV | 50,697 | $2.3M | 1.1% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 14 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| ABVX ABIVAX SA | 17,000 | $2.3M | 1.1% |
| VIR VIR BIOTECHNOLOGY INC | 220,000 | $2.2M | 1.0% |
| BIOA BIOAGE LABS INC | 69,000 | $1.7M | 0.8% |
| NVO NOVO NORDISK A/S | 24,000 | $1.2M | 0.5% |
| ADAG ADAGENE INC | 240,000 | $1.0M | 0.5% |
| DFTX DEFINIUM THERAPEUTICS INC | 20,000 | $940.8K | 0.4% |
| SLN SILENCE THERAPEUTICS PLC | 71,218 | $782.0K | 0.4% |
| FDMT 4D MOLECULAR THERAPEUTICS INC | 48,505 | $645.1K | 0.3% |
| URGN UROGEN PHARMA LTD | 16,487 | $606.7K | 0.3% |
| CAMP CAMP4 THERAPEUTICS CORP | 120,000 | $524.4K | 0.2% |
| SVRA SAVARA INC | 80,000 | $492.8K | 0.2% |
| ALT ALTIMMUNE INC | 152,681 | $464.1K | 0.2% |
| CAPR CAPRICOR THERAPEUTICS INC | 14,352 | $345.6K | 0.2% |
| IVVD INVIVYD INC | 342,275 | $298.6K | 0.1% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 15 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| NVCR NOVOCURE LTD | 202,330 | $2.2M | 1.3% |
| ENGN ENGENE HOLDINGS INC | 250,000 | $1.7M | 1.0% |
| RARE ULTRAGENYX PHARMACEUTICAL INC | 62,000 | $1.3M | 0.7% |
| KALVISTA PHARMACEUTICALS INC | 57,000 | $1.1M | 0.7% |
| VSTM VERASTEM INC | 150,000 | $795.0K | 0.5% |
| APGE APOGEE THERAPEUTICS INC | 9,000 | $757.5K | 0.4% |
| APELLIS PHARMACEUTICALS INC | 14,000 | $563.2K | 0.3% |
| IDYA IDEAYA BIOSCIENCES INC | 16,860 | $561.8K | 0.3% |
| RCUS ARCUS BIOSCIENCES INC | 25,889 | $559.2K | 0.3% |
| RGNX REGENXBIO INC | 66,270 | $555.3K | 0.3% |
| RCKT ROCKET PHARMACEUTICALS INC | 127,025 | $454.8K | 0.3% |
| VIRIDIAN THERAPEUTICS INC | 20,100 | $393.2K | 0.2% |
| OM OUTSET MEDICAL INC | 98,882 | $379.7K | 0.2% |
| PHR PHREESIA INC | 14,300 | $119.8K | <0.1% |
| ZNTL ZENTALIS PHARMACEUTICALS INC | 17,503 | $41.0K | <0.1% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| KLAC KLA CORPORATION | 19,883 | 178,471 | +797.6% | $53.8M |
| NKTR NEKTAR THERAPEUTICS | 31,000 | 81,000 | +161.3% | $5.7M |
| HALO HALOZYME THERAPEUTICS INC | 10,100 | 33,251 | +229.2% | $2.6M |
| CORT CORCEPT THERAPEUTICS INC | 47,200 | 57,200 | +21.2% | $5.0M |
| BIIB BIOGEN INC | 5,000 | 9,000 | +80.0% | $1.9M |
| ZBIO ZENAS BIOPHARMA INC | 70,000 | 93,601 | +33.7% | $2.4M |
| VERA VERA THERAPEUTICS INC | 44,000 | 57,758 | +31.3% | $2.5M |
| CMPX COMPASS THERAPEUTICS INC | 1,465,867 | 1,675,000 | +14.3% | $3.7M |
| SLDB SOLID BIOSCIENCES INC | 625,980 | 666,196 | +6.4% | $6.7M |
| GRCE GRACE THERAPEUTICS INC | 50,000 | 120,000 | +140.0% | $272.4K |
| QDEL QUIDELORTHO CORP | 82,548 | 89,377 | +8.3% | $1.6M |
| BBIO BRIDGEBIO PHARMA INC | 8,688 | 8,741 | +0.6% | $651.0K |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| CMPS COMPASS PATHWAYS LTD | 375,000 | 30,000 | -92.0% | $424.5K |
| GPCR STRUCTURE THERAPEUTICS INC | 100,000 | 24,000 | -76.0% | $1.3M |
| OCUL OCULAR THERAPEUTIX INC | 320,000 | 20,655 | -93.5% | $202.8K |
| QURE UNIQURE NV | 100,697 | 50,697 | -49.7% | $2.3M |
| PHAT PHATHOM PHARMACEUTICALS INC | 195,000 | 55,000 | -71.8% | $596.8K |
| NTLA INTELLIA THERAPEUTICS INC | 445,400 | 385,900 | -13.4% | $6.8M |
| STOK STOKE THERAPEUTICS INC | 210,000 | 178,110 | -15.2% | $5.8M |
| BCYC BICYCLE THERAPEUTICS PLC | 463,599 | 313,616 | -32.4% | $1.3M |
| BMY BRISTOL-MYERS SQUIBB CO | 306,268 | 297,243 | -2.9% | $17.1M |
| LRCX LAM RESEARCH CORPORATION | 36,000 | 35,000 | -2.8% | $15.2M |
| KPTI KARYOPHARM THERAPEUTICS INC | 83,952 | 42,952 | -48.8% | $419.6K |
| PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC | 1,500,000 | 1,350,000 | -10.0% | $2.3M |
CIK 1618205 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
